Spotlight On Upcoming Oral Arguments – October 2020

The following telephone arguments will be available to the public live.  Access information will be available by 9 AM ET each day of argument at: http://www.cafc.uscourts.gov/public-access-arguments.

Monday, October 5, 2020

Vectura Limited v. GlaxoSimthKline LLC, No. 20-1054

This case involves U.S. Patent No. 8,303,991, relating to composite active particles comprising particles of active material and an additive material (e.g., magnesium stearate (“MgSt”)) on the surface of the particles. An asserted claim further requires that the additive material promotes the dispersion of the active particles upon actuation of a delivery device. Vectura filed suit alleging that GSK infringed the claim, and the jury found infringement. GSK then moved for judgement as a matter of law or a new trial, arguing that Vectura had not presented sufficient evidence that GSK's accused products practiced the “dispersion” limitation of the claim. The court rejected the argument.